Skip to content

MNC

MNC - MNC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051685
Enrollment
34
Registered
2023-07-21
Start date
2022-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lack of clarity and definitive uncertainty regarding the impact of switching from tobacco smoking to vape use on the number of buccal and palatal mucosal micronucleus cells.

Interventions

smokers smokers switched to vaping

Sponsors

universitas Padjadjaran
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: smokers

Exclusion criteria

Exclusion criteria: having an acute illness that required treatment (subjects who had a viral infection) within 4 weeks before the enrolment visit, having oral soft tissue disease or any type of gingival overgrowth other than those caused by plaque, suffering from periodontitis, having a history of tooth loss due to periodontitis, being treated with anticoagulant therapy in the previous six months, using prostheses or orthodontic appliances, history of alcoholism or drug/chemical abuse, taking any drug or substance (other than tobacco) that interferes with the cyclooxygenase pathway (e.g. anti-inflammatory drugs including aspirin and ibuprofen) in the 14 days prior to the enrolment visit, taking antibiotics in the 14 days prior to the enrolment visit, breastfeeding or pregnant women.

Design outcomes

Primary

MeasureTime frame
mnc decrease

Countries

Asia(except Japan)

Contacts

Public ContactIndra Pribadi

Universitas Padjadjaran Periodonsia

indra.mustika@unpad.ac.id+628562143662

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026